TCI GENE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80 TWD | -0.74% |
|
-0.74% | -4.88% |
| 05-03 | TCI GENE Inc. Approves the Cash Dividend for the Year Ended December 31, 2023 | CI |
| 03-15 | TCI GENE Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 424M 13.08M 1.03B | Sales 2023 | 334M 10.29M 808M | Capitalization | 2.23B 68.62M 5.39B |
|---|---|---|---|---|---|
| Net income 2022 | 72M 2.22M 174M | Net income 2023 | 11M 339K 26.63M | EV / Sales 2022 | 5.13 x |
| Net cash position 2022 | 933M 28.78M 2.26B | Net cash position 2023 | 891M 27.47M 2.16B | EV / Sales 2023 | 4 x |
| P/E ratio 2022 |
40.1
x | P/E ratio 2023 |
191
x | Employees | - |
| Yield 2022 |
1.7% | Yield 2023 |
-
| Free-Float | 21.01% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.74% | ||
| 1 week | -0.74% | ||
| Current month | -0.74% | ||
| 1 month | +2.56% | ||
| 3 months | -0.62% | ||
| 6 months | -6.65% | ||
| Current year | -4.88% |
1 week
79.20
80.60
1 month
76.0081.20
Current year
76.0093.90
1 year
76.00132.50
3 years
76.00175.00
5 years
76.00175.00
10 years
76.00175.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yung Hsiang Lin
CEO | Chief Executive Officer | - | 16/05/12 |
I Ping Yan
DFI | Director of Finance/CFO | - | 03/10/21 |
Hsiao Tsui Chang
AUD | Comptroller/Controller/Auditor | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yung Hsiang Lin
CEO | Chief Executive Officer | - | 16/05/12 |
Yung Hao Lin
BRD | Director/Board Member | - | 29/11/21 |
Ching Ting Chen
BRD | Director/Board Member | - | 22/12/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/06/24 | 80 | -0.74% | 3,020 |
| 06/06/24 | 80.6 | 0.00% | 100 |
| 05/06/24 | 80.6 | 0.00% | 400 |
| 04/06/24 | 80.6 | +0.37% | 1,000 |
| 03/06/24 | 80.3 | -0.37% | 12,981 |
End-of-day quote Taipei Exchange, June 06, 2024
More quotes
TCI Gene Inc is a Taiwan-based company mainly engaged in the provision of genetic testing services. The main products include genetic testing services, virus testing services, cell experiment services, production of adipose-derived stem cell preparations for the treatment of degenerative arthritis and knee cartilage defects, production of natural killer cell preparations for the treatment of solid cancer, and personalized genetic health food. Genetic testing technology is mainly in the field of disease risk and drug genetic testing, including comprehensive genetic testing, child growth and development genetic testing, youth beauty genetic testing, weight management genetic testing, anti-aging genetic testing, cardiovascular drug genetic testing and depression/insomnia Pharmacogenetic testing. The Company's products are mainly sold in Taiwan.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.88% | 65.25M | |
| -22.13% | 7.9B | |
| +76.16% | 4.53B | |
| +9.28% | 2.78B | |
| -50.41% | 1.99B | |
| -19.59% | 1.66B | |
| -20.07% | 1.49B | |
| +19.31% | 1.23B | |
| -45.78% | 1.1B | |
| +21.04% | 996M |
- Stock Market
- Equities
- 6879 Stock
